Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06717360
PHASE3
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
View on ClinicalTrials.gov
Summary
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Official title: A Multicenter, Randomized, Double-blinded, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Key Details
Gender
All
Age Range
19 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-06
Completion Date
2027-06
Last Updated
2024-12-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
AG2304T
AG2304T, QD, PO
DRUG
AG2304R
AG2304R, QD, PO